{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:42:09Z","timestamp":1791225729125,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ctrv.2024.102704","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T10:18:13Z","timestamp":1709288293000},"page":"102704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-2135","authenticated-orcid":false,"given":"K.R.J.","family":"Kistemaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Brinkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"de Graeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.L.","family":"Burchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.H.","family":"Steegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"van Zuylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctrv.2024.102704_b0005","first-page":"591","article-title":"Update on prevalence of pain in patients with cancer 2022","volume":"15","author":"Snijders","year":"2023","journal-title":"A System Literature Rev Meta-Anal Cancers"},{"key":"10.1016\/j.ctrv.2024.102704_b0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2407-8-177","article-title":"Depression and quality of life in cancer patients with and without pain: the role of pain beliefs","volume":"8","author":"Tavoli","year":"2008","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102704_b0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/NJH.0000000000000507","article-title":"Cancer pain and quality of life","volume":"21","author":"Rodriguez","year":"2019","journal-title":"J Hosp Palliat Nurs"},{"key":"10.1016\/j.ctrv.2024.102704_b0020","unstructured":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"9784","key":"10.1016\/j.ctrv.2024.102704_b0025","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0140-6736(11)60236-5","article-title":"Treatment of cancer pain","volume":"377","author":"Portenoy","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2024.102704_b0030","doi-asserted-by":"crossref","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol 2018; 29(Suppl 4): iv166-iv91. 10.1093\/annonc\/mdy152.","DOI":"10.1093\/annonc\/mdy152"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.gastro.2018.08.018","article-title":"American Gastroenterological Association Institute clinical guidelines C. American gastroenterological association institute technical review on the medical management of opioid-induced constipation","volume":"156","author":"Hanson","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/j.pain.0000000000002024","article-title":"Opioid-induced constipation in patients with cancer: a \u201creal-world,\u201d multicentre, observational study of diagnostic criteria and clinical features","volume":"162","author":"Davies","year":"2021","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102704_b0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5055\/jom.2009.0014","article-title":"Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and wellness survey","volume":"5","author":"Bell","year":"2009","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.ctrv.2024.102704_b0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.sjpain.2015.12.007","article-title":"Opioid-induced constipation, use of laxatives, and health-related quality of life","volume":"11","author":"Christensen","year":"2016","journal-title":"Scand J Pain"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102704_b0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0269216312450358","article-title":"A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease","volume":"27","author":"Dhingra","year":"2013","journal-title":"Palliat Med"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3111\/13696990903584436","article-title":"Quality of life in relation to constipation among opioid users","volume":"13","author":"Penning-van Beest","year":"2010","journal-title":"J Med Econ"},{"issue":"7","key":"10.1016\/j.ctrv.2024.102704_b0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","article-title":"Opioid-induced bowel dysfunction: pathophysiology and potential new therapies","volume":"63","author":"Kurz","year":"2003","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102704_b0070","first-page":"613","article-title":"Management of opioid-induced bowel dysfunction in cancer patients","volume":"12","author":"Tamayo","year":"2004","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.ctrv.2024.102704_b0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11864-019-0686-6","article-title":"Opioid-induced constipation in oncological patients: new strategies of management","volume":"20","author":"Mesia","year":"2019","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid-induced constipation: European expert consensus statement","volume":"7","author":"Farmer","year":"2019","journal-title":"United Eur Gastroenterol J"},{"issue":"12","key":"10.1016\/j.ctrv.2024.102704_b0085","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/pme.12937","article-title":"Consensus recommendations on initiating prescription therapies for opioid-induced constipation","volume":"16","author":"Argoff","year":"2015","journal-title":"Pain Med"},{"issue":"12","key":"10.1016\/j.ctrv.2024.102704_b0090","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3111\/13696998.2013.851083","article-title":"Further validation of the psychometric properties of the bowel function index for evaluating opioid-induced constipation (OIC)","volume":"16","author":"Abramowitz","year":"2013","journal-title":"J Med Econ"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1185\/03007995.2010.535270","article-title":"Observational, nonintervention, multicenter study for validation of the bowel function index for constipation in European countries","volume":"27","author":"Rentz","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102704_b0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3111\/13696990903430481","article-title":"Validation of the bowel function index to detect clinically meaningful changes in opioid-induced constipation","volume":"12","author":"Rentz","year":"2009","journal-title":"J Med Econ"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102704_b0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejpain.2005.03.008","article-title":"Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain","volume":"10","author":"Slappendel","year":"2006","journal-title":"Eur J Pain"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/23809000.2016.1131595","article-title":"Opioid induced constipation in cancer patients: pathophysiology, diagnosis and treatment","volume":"1","author":"Rumman","year":"2016","journal-title":"Expert Rev Quality Life Cancer Care"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102704_b0115","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s40122-021-00271-y","article-title":"Impact and consequences of opioid-induced constipation: a survey of patients","volume":"10","author":"Varrassi","year":"2021","journal-title":"Pain Ther"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/SPC.0b013e3282f53146","article-title":"Management of constipation in palliative care patients","volume":"2","author":"Clemens","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.ctrv.2024.102704_b0125","first-page":"414","article-title":"Chemotherapy-induced constipation and diarrhea: pathophysiology","volume":"7","author":"McQuade","year":"2016","journal-title":"Curr Emerging Treatments Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","article-title":"American gastroenterological association institute clinical guidelines C. American gastroenterological association institute guideline on the medical management of opioid-induced constipation","volume":"156","author":"Crockett","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctrv.2024.102704_b0135","doi-asserted-by":"crossref","unstructured":"Larkin PJ, Cherny NI, La Carpia D, Guglielmo M, Ostgathe C, Scotte F, et al. Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018; 29(Suppl 4): iv111-iv25. 10.1093\/annonc\/mdy148.","DOI":"10.1093\/annonc\/mdy148"},{"key":"10.1016\/j.ctrv.2024.102704_b0140","unstructured":"Palliaweb. Guideline Constipation in the palliative phase. [Available from: https:\/\/palliaweb.nl\/richtlijnen-palliatieve-zorg\/richtlijn\/obstipatie\/preventie\/opioidgeinduceerde-obsitapatie. Accessed 16 Nov 2022."},{"issue":"4","key":"10.1016\/j.ctrv.2024.102704_b0145","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3122\/jabfm.2011.04.100272","article-title":"Chronic constipation: an evidence-based review","volume":"24","author":"Leung","year":"2011","journal-title":"J Am Board Fam Med"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102704_b0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/gut.2010.227132","article-title":"Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis","volume":"60","author":"Ford","year":"2011","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.ctrv.2024.102704_b0155","first-page":"e16201","article-title":"Efficacy and safety of peripherally acting mu-opioid receptor antagonist (PAMORAs) for the Management of Patients with Opioid-Induced Constipation: a systematic review","volume":"13","author":"Rekatsina","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102704_b0160","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/jpet.116.239061","article-title":"Pharmacologic profile of naloxegol, a peripherally acting micro-opioid receptor antagonist, for the treatment of opioid-induced constipation","volume":"361","author":"Floettmann","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102704_b0165","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2982.2004.00513.x","article-title":"Opioids and the gut: pharmacology and current clinical experience","volume":"16","author":"De Schepper","year":"2004","journal-title":"Neurogastroenterol Motil"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102704_b0170","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12325-010-0057-y","article-title":"Fixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipation","volume":"27","author":"Mueller-Lissner","year":"2010","journal-title":"Adv Ther"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102704_b0175","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.cgh.2018.01.021","article-title":"Efficacy of treatments for opioid-induced constipation: systematic review and meta-analysis","volume":"16","author":"Nee","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/apt.15791","article-title":"Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation","volume":"52","author":"Vijayvargiya","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ctrv.2024.102704_b0185","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org\/handbook."},{"issue":"7","key":"10.1016\/j.ctrv.2024.102704_b0190","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ctrv.2024.102704_b0195","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ctrv.2024.102704_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2023.03.003","article-title":"GRADE guidance 36: updates to GRADE's approach to addressing inconsistency","author":"Guyatt","year":"2023","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0885-3924(97)00276-5","article-title":"Efficacy of senna versus lactulose in terminal cancer patients treated with opioids","volume":"15","author":"Agra","year":"1998","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0210","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0269216311418869","article-title":"A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone\/naloxone prolonged-release tablets in patients with moderate\/severe, chronic cancer pain","volume":"26","author":"Ahmedzai","year":"2012","journal-title":"Palliat Med"},{"issue":"7","key":"10.1016\/j.ctrv.2024.102704_b0215","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/jpm.2014.0362","article-title":"Fixed-dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: results of a randomized, placebo-controlled study and open-label extension","volume":"18","author":"Bull","year":"2015","journal-title":"J Palliat Med"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102704_b0220","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ejp.1054","article-title":"A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160\/80 mg daily) vs oxycodone PR","volume":"21","author":"Dupoiron","year":"2017","journal-title":"Eur J Pain"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102704_b0225","first-page":"1271","article-title":"Itopride increases the effectiveness of the management of opioid-induced constipation in palliative care patients: an observational non-interventional study","volume":"18","author":"Dzierzanowski","year":"2022","journal-title":"Arch Med Sci"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102704_b0230","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00520-019-04944-5","article-title":"PEG vs. sennosides for opioid-induced constipation in cancer care","volume":"28","author":"Hawley","year":"2020","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102704_b0235","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/jpm.2007.0178","article-title":"A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer","volume":"11","author":"Hawley","year":"2008","journal-title":"J Palliat Med"},{"issue":"34","key":"10.1016\/j.ctrv.2024.102704_b0240","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1200\/JCO.2017.73.0853","article-title":"Randomized phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer","volume":"35","author":"Katakami","year":"2017","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.ctrv.2024.102704_b0245","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1200\/JCO.2016.70.8453","article-title":"Phase IIb, randomized, double-blind, placebo-controlled study of naldemedine for the treatment of opioid-induced constipation in patients with cancer","volume":"35","author":"Katakami","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2024.102704_b0250","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.2147\/DDDT.S92998","article-title":"Efficacy and tolerability of oral oxycodone and oxycodone\/naloxone combination in opioid-naive cancer patients: a propensity analysis","volume":"9","author":"Lazzari","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40880-017-0241-4","article-title":"Efficacy and safety of controlled-release oxycodone\/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial","volume":"36","author":"Lee","year":"2017","journal-title":"Chin J Cancer"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102704_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092112","article-title":"Effectiveness of naldemedine compared with magnesium oxide in preventing opioid-induced constipation: a randomized controlled trial","volume":"14","author":"Ozaki","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102704_b0265","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jpainsymman.2007.12.005","article-title":"Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study","volume":"35","author":"Portenoy","year":"2008","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102704_b0270","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0885-3924(98)00080-3","article-title":"Managing morphine-induced constipation: a controlled comparison of an Ayurvedic formulation and senna","volume":"16","author":"Ramesh","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ctrv.2024.102704_b0275","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2147\/JPR.S141928","article-title":"A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis","volume":"10","author":"Roberto","year":"2017","journal-title":"J Pain Res"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0280","first-page":"39","article-title":"Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients","volume":"7","author":"Slatkin","year":"2009","journal-title":"J Support Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102704_b0285","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/026921639601000208","article-title":"An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer","volume":"10","author":"Sykes","year":"1996","journal-title":"Palliat Med"},{"issue":"22","key":"10.1016\/j.ctrv.2024.102704_b0290","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","article-title":"Methylnaltrexone for opioid-induced constipation in advanced illness","volume":"358","author":"Thomas","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102704_b0295","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1002\/cam4.2341","article-title":"Incidence of opioid-induced constipation in Japanese patients with cancer pain: a prospective observational cohort study","volume":"8","author":"Tokoro","year":"2019","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0300","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2354.2011.01286.x","article-title":"Laxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose","volume":"21","author":"Wirz","year":"2012","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102704_b0305","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jpainsymman.2017.07.025","article-title":"Opioid-induced constipation relief from fixed-ratio combination prolonged-release oxycodone\/naloxone compared with oxycodone and morphine for chronic nonmalignant pain: a systematic review and meta-analysis of randomized controlled trials","volume":"54","author":"Huang","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ctrv.2024.102704_b0310","unstructured":"Clinicaltrialsregisters.eu. 2006 [Available from: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2005-001974-28\/results. Accessed on 8 June 2023."},{"key":"10.1016\/j.ctrv.2024.102704_b0315","unstructured":"Clinicaltrialsregisters.eu. 2011 [Available from: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2009-012051-20\/results. Accessed on 8 June 2023."},{"key":"10.1016\/j.ctrv.2024.102704_b0320","unstructured":"Clinicaltrialsregisters.eu. 2012 [Available from: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2008-005315-18\/results. Accessed on 8 June 2023."},{"key":"10.1016\/j.ctrv.2024.102704_b0325","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/nu13020421","article-title":"Magnesium oxide in constipation","volume":"13","author":"Mori","year":"2021","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102704_b0330","first-page":"601","article-title":"Naldemedine (symproic) for the treatment of opioid-induced constipation","volume":"43","author":"Hu","year":"2018","journal-title":"P T"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102704_b0335","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/j.1552-4604.1997.tb04264.x","article-title":"Tolerance and efficacy of polyethylene glycol 3350\/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial","volume":"37","author":"Freedman","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ctrv.2024.102704_b0340","unstructured":"EMA. Summary of product characteristics (annex I) 2022 [Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/relistor-epar-product-information_en.pdf. Accessed on 19-05-2023."},{"key":"10.1016\/j.ctrv.2024.102704_b0345","unstructured":"FDA. RELISTOR (methylnaltrexone bromide) 2017 [Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/021964s018,208271s002lbl.pdf. Accessed 19-05-2023."},{"issue":"9","key":"10.1016\/j.ctrv.2024.102704_b0350","article-title":"Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care","volume":"9","author":"Candy","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102704_b0355","doi-asserted-by":"crossref","first-page":"E211","DOI":"10.1188\/20.ONF.E211-E224","article-title":"Management of opioid-induced and non-opioid-related constipation in patients with cancer: systematic review and meta-analysis","volume":"47","author":"Ginex","year":"2020","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102704_b0360","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1200\/OP.21.00466","article-title":"Financial burden of drugs prescribed for cancer-associated symptoms","volume":"18","author":"Gupta","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"12","key":"10.1016\/j.ctrv.2024.102704_b0365","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMsa1202397","article-title":"A randomized study of how physicians interpret research funding disclosures","volume":"367","author":"Kesselheim","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ctrv.2024.102704_b0370","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.amjmed.2004.05.029","article-title":"Association of funding and findings of pharmaceutical research at a meeting of a medical professional society","volume":"117","author":"Finucane","year":"2004","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102704_b0375","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpainsymman.2006.07.011","article-title":"Differences in the prevalence and severity of side effects based on type of analgesic prescription in patients with chronic cancer pain","volume":"33","author":"Villars","year":"2007","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102704_b0380","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40122-020-00204-1","article-title":"Correction to: what to do and what not to do in the management of opioid-induced constipation: a choosing wisely report","volume":"9","author":"Alvaro","year":"2020","journal-title":"Pain Ther"}],"updated-by":[{"DOI":"10.1016\/j.ctrv.2024.102738","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737224000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737224000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T08:11:56Z","timestamp":1713946316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737224000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":76,"alternative-id":["S0305737224000227"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2024.102704","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ctrv.2024.102738","asserted-by":"object"}]},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2024.102704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102704"}}